BlackRock Capital Allocation Term Trust (NYSE:BCAT) Short Interest Update

BlackRock Capital Allocation Term Trust (NYSE:BCATGet Free Report) saw a significant drop in short interest in March. As of March 31st, there was short interest totaling 395,919 shares, a drop of 51.8% from the March 15th total of 821,995 shares. Approximately 0.4% of the company’s stock are short sold. Based on an average trading volume of 769,213 shares, the short-interest ratio is currently 0.5 days.

BlackRock Capital Allocation Term Trust Stock Performance

Shares of BlackRock Capital Allocation Term Trust stock opened at $14.88 on Friday. The business has a 50-day moving average of $14.76 and a 200-day moving average of $14.59. BlackRock Capital Allocation Term Trust has a 1-year low of $13.50 and a 1-year high of $15.41.

BlackRock Capital Allocation Term Trust Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, June 15th will be paid a dividend of $0.2579 per share. The ex-dividend date is Monday, June 15th. This represents a c) annualized dividend and a dividend yield of 20.8%.

Institutional Trading of BlackRock Capital Allocation Term Trust

Large investors have recently modified their holdings of the business. Keener Financial Planning LLC acquired a new stake in shares of BlackRock Capital Allocation Term Trust during the third quarter valued at about $29,000. Geneos Wealth Management Inc. grew its stake in shares of BlackRock Capital Allocation Term Trust by 341.7% during the second quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock valued at $31,000 after acquiring an additional 1,582 shares in the last quarter. N.E.W. Advisory Services LLC grew its stake in shares of BlackRock Capital Allocation Term Trust by 100.0% during the fourth quarter. N.E.W. Advisory Services LLC now owns 2,400 shares of the company’s stock valued at $34,000 after acquiring an additional 1,200 shares in the last quarter. AdvisorNet Financial Inc grew its stake in shares of BlackRock Capital Allocation Term Trust by 53.8% during the third quarter. AdvisorNet Financial Inc now owns 2,995 shares of the company’s stock valued at $44,000 after acquiring an additional 1,048 shares in the last quarter. Finally, McIlrath & Eck LLC grew its stake in shares of BlackRock Capital Allocation Term Trust by 971.1% during the third quarter. McIlrath & Eck LLC now owns 2,999 shares of the company’s stock valued at $44,000 after acquiring an additional 2,719 shares in the last quarter. 36.12% of the stock is currently owned by institutional investors and hedge funds.

About BlackRock Capital Allocation Term Trust

(Get Free Report)

BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.

BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.

Featured Stories

Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.